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Animal studies have shown that exposure to tobacco smoke (ETS)
leads to inﬂammation and cardiac remodeling, characterized by heart
hypertrophy, higher diastolic dimension of the left ventricle and
impaired systolic function [1–3]. Although the precise mechanisms of
smoking-induced alterations remain unclear, the evidence supports
the hypothesis that oxidative stress and inﬂammation provide the
pathophysiological link between ETS and heart alterations [4,5]. In
recent years, vitamin D has emerged as an important nutrient for
heart health and its deﬁciency has been linked to increased
cardiovascular disease risk [6,7]. In heart aggression models, vitamin
D (VD) supplementation attenuated the cardiac remodeling by
inﬂuencing the contractility, hypertrophy, renin angiotensin system,
ﬁbrosis and inﬂammation [8–10]. Given that vitamin D may modulate
cardiac alterations following different injuries, the objective of this
study was to investigate the effect of vitamin D supplementation on
cardiac remodeling induced by tobacco-smoke exposure in rats. Rats
were allocated into six groups: 1) VD0-no ETS, without VD supple-
mentation and no ETS, 2)VD1-no ETS, supplementation of 1000 IU VD/
kg diet and no ETS, 3) VD3-no ETS, supplementation of 3000 IU VD/kg,
4) VD0-ETS, ETSwithout VD supplementation, 5) VD1-ETS, ETSwith VD
supplementation of 1000 IU, and 6) VD3-ETS, ETS with VD supple-
mentation of 3000 IU. After two months of tobacco exposure and VD
supplementation, the animals underwent blood pressure measure and
echocardiography. Collagen volume fraction, myocyte cross-sectional
area (MCSA), serum 25-hydroxycholecalciferol, oxidative stress and
cytokine production in heart tissue were evaluated.
For both factors (VD and ETS), the groups did not differ
signiﬁcantly in ﬁnal body weight, tibia length or food consumption.
As to echocardiographic data, no interaction was observed in all
variables. Only the ETS factor presented differences, namely enlarge-
ment of the left chamber compared to the no ETS animals. The left
ventricle end-diastolic diameter corrected for the tibia length (LVDD),
left ventricle posterior wall (LVPW) and left ventricle mass (LVM) were
increased in the ETS animals, with preserved relative wall thickness,
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suggesting eccentric hypertrophy. No differences were observed in the
other echocardiographic variables. For systolic pressure, no interaction
was observed. A difference was shown only in the ETS factor, in which
ETS animals had higher pressure values compared to their no-ETS
counterparts.
The morphometric data revealed interaction between factors. The
MCSA, which is an index of ventricular hypertrophy, was greater in the
VD0-ETS group than in VD0-no ETS (Table 1). No difference was
observed for interstitial collagen. In addition, there was no interaction
between factors or differences in cardiac levels of IFN-γ, TNF-α and IL-
10.
The ETS led to greater concentration of lipid hydroperoxide and
lower activities of catalase and superoxide dismutase in group VD0-
ETS compared to VD0-no ETS (Table 1).
Vitamin D supplementation produced no effect on echocardio-
graphic variables among ETS animals. However, VD supplementation
of 3000 UI/kg led to lower MCSA values in ETS animals.
With regard to oxidative stress enzymes, an interaction was
observed between VD and ETS. Under VD treatment, lower lipid
hydroperoxide and higher superoxide dismutase and catalase activity
were observed in ETS animals. For glutathione peroxidase, differences
were observed only in relation to the VD factor.
Vitamin D did not cause changes in the groups without exposure to
tobacco smoke.
Exposure to tobacco smoke — Our study has found that exposure to
tobacco smoke led to remodeling with eccentric hypertrophy and
changes in oxidative status, in addition to signiﬁcant increases in
arterial blood pressure, compared to nonsmokers. These observations
are consistent with previous studies that reported an increase in
posterior wall thickness and LV mass, higher LV diastolic diameter,
blood pressure elevation and reduced antioxidant activity after
exposure to tobacco smoke [11,12].
In the present study, augmented oxidative stress might be involved
in ETS-induced remodeling. Substantial evidence shows that cigarette
smoke can induce increased production of reactive oxygen metabo-
lites and species by augmenting oxidative stress. Besides the
production of ROS, cigarette smoke weakens antioxidant defense
system, such as antioxidant enzymes [13]. In agreement with these
data, the present study found that ETS increased lipoperoxidation and
decreased both catalase and superoxide dismutase activities, suggest-
ing elevated oxidative stress status.
Exposure to tobacco smoke and vitamin D supplementation — In the
present study, VD supplementation attenuated cardiac hypertrophy
after ETS. VD supplementation in salt-sensitive Dahl rats was
associated with lower heart weight and LV mass reduction, lower
posterior wall thickness and end diastolic pressure and increased
shortening fraction [14]. Kong et al. reported a reduction in the
thickness of the LV posterior wall by echocardiogram and LV cross-
sectional histology, and reduction of the diameter of cardiomyocytes
in spontaneously hypertensive rats after treatment with vitamin D
[10]. Clinical trials in hemodialysis patients treated with vitamin D
showed reduced LV hypertrophy [6]. In the present study, vitamin D
supplementation attenuated hypertrophy, expressed by lower values
of MCSA.
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In addition to hypertrophy, there is evidence that vitamin D
participates in the modulation of other factors in cardiac remodeling,
such as oxidative stress [15]. There are reports on the role of vitamin D
as an antioxidant agent in tissues such as liver, kidney and pancreas
[16,17]. More recently, treatment with vitamin D improved the
oxidative stress in uremic rats by preventing the depletion of SOD
and GSH-Px [18].
Therefore vitamin D modulates cardiac remodeling induced by
exposure to tobacco smoke by the action of its antioxidant capacity on
cardiac hypertrophy.
The authors of this manuscript have certiﬁed that they comply
with the Principles of Ethical Publishing in the International Journal of
Cardiology (Shewan and Coats 2010; 144:1–2).
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Table 1
Myocyte cross-sectional area and cardiac oxidative stress measurements.
ETS Vitamin
dose
n MCSA
q(μm2)
Lipid hydroperoxide
(nmol/g tissue)
Catalase
(μmol/mg protein)
Glutathione peroxidase
(nmol/mg tissue)
Superoxide dismutase
(nmol/mg protein)
No ETS VD0 8 182±12.1a,A,C 337±25.8a,A 1.1±0.06a 37.8±2.9 4.02±0.20a
No ETS VD1 8 233±12.1A 439±25.8b,A 0.9±0.06 36.8±2.9 4.12±0.20
No ETS VD3 8 237±12.1C 359±25.8 0.9±0.06 46.2±2.9 3.89±0.20
ETS VD0 12 267±10.8a,F 716±22.1a,D,F 0.6±0.05a,D,F 29.9±2.5 2.42±0.17a,D,F
ETS VD1 10 251±10.8 519±25.8b,D,E 0.8±0.06D 42.6±2.9 3.79±0.20D
ETS VD3 8 222±10.8F 426±28.0E,F 0.8±0.05F 41.3±3.2 3.94±0.22F
P1 (ETS) 0.005 b0.001 b0.001 b0.001 b0.001
P2 (VD) 0.331 b0.001 0.969 0.006 b0.001
P3 (ETSxVD) b0.001 b0.001 b0.001 0.056 b0.001
Data are expressed as mean±standard error of mean. n=number of rats. VD0=diet with no supplementation; VD1=diet supplemented with 1000 IU/kg of vitamin D;
VD3=diet supplemented with 3000 IU/kg of vitamin D; ETS=exposed to cigarette smoking; no ETS=not exposed to cigarette smoking; MCSA=myocyte cross-sectional area.
P1=p value of ETS effect; P2=p value of vitamin D effect; P3=p value of interaction. Equal letters are showing differences in the comparisons.
Comparisons for factor ETS: (a— ETS≠no ETSwithin VD0; b— ETS≠no ETSwithin VD1; c— ETS≠no ETSwithin VD3). Comparisons for factor Vitamin D: (A— VD0≠VD1within
no ETS; B — VD1≠VD3 within no ETS; C — VD0≠VD3 within no ETS) and (D — VD0≠VD1 within ETS; E — VD1≠VD3 within ETS; F — VD0≠VD3 within ETS).
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